Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists

被引：44

作者：

Abel, Ulrich ^{[1
]}

Schlueter, Thomas ^{[1
]}

Schulz, Andreas ^{[1
]}

Hambruch, Eva ^{[1
]}

Steeneck, Christoph ^{[1
]}

Hornberger, Martin ^{[1
]}

Hoffmann, Thomas ^{[1
]}

Perovic-Ottstadt, Sanja ^{[1
]}

Kinzel, Olaf ^{[1
]}

Burnet, Michael ^{[2
]}

Deuschle, Ulrich ^{[1
]}

Kremoser, Claus ^{[1
]}

机构：

[1] Phenex Pharmaceut AG, D-69123 Heidelberg, Germany

[2] Synovo GmbH, D-72076 Tubingen, Germany

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 16期

关键词：

Farnesoid X receptor; FXR agonist; GW4064; db/db mice; Metabolic syndrome; FARNESOID-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; BILE-ACIDS; IDENTIFICATION; HOMEOSTASIS; MICE;

D O I：

10.1016/j.bmcl.2010.06.084

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

To overcome the known liabilities of GW4064 a series of analogs were synthesized where the stilbene double bond is replaced by an oxymethylene or amino-methylene linker connecting a terminal benzoic acid with a substituted heteroaryl in the middle ring position. As a result we discovered compounds with increased potency in vitro that cause dose-dependent reduction of plasma triglycerides and cholesterol in db/db mice down to 2 x 1 mg/kg/day upon oral administration. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：4911 / 4917

页数：7

共 50 条

[1] Steroidal or non-steroidal FXR agonists - Is that the question?
Verbeke, Len
Nevens, Frederik
Laleman, Wim
JOURNAL OF HEPATOLOGY, 2017, 66 (04) : 680 - 681
[2] 3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonists
Zhang, Tao
Zhou, Jun-Hong
Shi, Liang-Wei
Zhu, Rui-Xin
Chen, Min-Bo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) : 2156 - 2160
[3] Non-steroidal glucocorticoid agonists
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (04) : 467 - 470
[4] Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries
Nicolaou, KC
Evans, RM
Roecker, AJ
Hughes, R
Downes, M
Pfefferkorn, JA
ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (06) : 908 - 920
[5] Steroidal and non-steroidal FXR agonists elicit clinically-relevant lipoprotein profiles in mice with chimeric humanized livers
Papazyan, R.
Rigbolt, K.
Lind, R.
Feigh, M.
Liu, J.
Dong, B.
Plummer, E.
Lewis, R. D., II
Roth, M.
Young, M.
JOURNAL OF HEPATOLOGY, 2018, 68 : S59 - S60
[6] Activation of FXR by steroidal or non-steroidal agonists causes an increase in LDL-cholesterol in mice with humanized chimeric liver
Liu, X.
Liu, J.
Dong, B.
Roth, J.
Young, M.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S611 - S611
[7] A design and iterative approach to non-steroidal and steroidal agonists
Biggadike, Keith
Coe, Diane M.
Mclay, Lain M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 671 - 671
[8] Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist
Kainuma, Masahiko
Makishima, Makoto
Hashimoto, Yuichi
Miyachi, Hiroyuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2587 - 2600
[9] Synthesis and pharmacological evaluations of novel conjugates of steroidal-antedrugs and non-steroidal anti-inflammatory drugs
McLean, HM
Heiman, AS
Lee, HJ
MEDICINAL CHEMISTRY RESEARCH, 2002, 11 (05) : 255 - 277
[10] Synthesis and discovery of andrographolide derivatives as non-steroidal farnesoid X receptor (FXR) antagonists
Liu, Zhuyun
Law, Wai-Kit
Wang, Decai
Nie, Xin
Sheng, Dekuan
Song, Genrui
Guo, Kai
Wei, Ping
Ouyang, Pingkai
Wong, Chi-Wai
Zhou, Guo-Chun
RSC ADVANCES, 2014, 4 (26): : 13533 - 13545

← 1 2 3 4 5 →